GW's Gover on Cannabis-Derived Drug for Rare ...

Brad Smith, President of Microsoft, discusses updated content from his book "Tools and Weapons: The Promise and the Peril of the Digital Age." Jennifer Surane, Finance Reporter for Bloomberg News, talks about her story, "Wall Street Limps Into Post-Labor Day Return Derailed by De ...  Show more

Phil Orlando, Chief Equity Market Strategist and Head of Client Portfolio Management at Federated Hermes, talks jobs and markets. Skylar Woodhouse, Reporter for Bloomberg News, discusses the aftermath of Hurricane Ida in New York City. Tom Bohn, President & CEO of the Association ...  Show more

Ireland-based biopharmaceutical company Jazz Pharmaceuticals buys the biggest acquisition in the cannabis industry to date after agreeing to buy GW Pharmaceuticals for $7.2 billion last week. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.c ...  Show more

The Interview. Jason Wild, founder of JW Asset Management, sits down with Tony Greer, founder of TG Macro, to discuss his career journey from pharmacist to investor with a firm that oversees $1 billion through a mix of investments in pharmaceuticals and cannabis producers. Wild’s ...  Show more

Jay Z’s cannabis company is set to produce 900,000 pounds of cannabis. Marc Wasserman talks about a bust in England and Craig Wasserman has cannabis news. Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/listener for privacy information. 

Tezlyn chats with Dr. Lance McCarthy about how Black Americans can benefit from the cannabis industry beyond owning a dispensary and how the industry is changing the criminal justice system.   Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio. ...  Show more